Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Lymph Node Excision × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Endometrial Neoplasms 7 Lymphatic Metastasis 6 Uterine Cervical Neoplasms 5 Urinary Bladder Neoplasms 3 Breast Neoplasms 3 Thyroid Cancer, Papillary 2 Stomach Neoplasms 2 Prostatic Neoplasms 2 Postoperative Complications 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Lymphedema 2 Lung Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Clinical Stage I Gastric Cancer AJCC v8 2 Carcinoma, Transitional Cell 2 Vulvar Neoplasms 1 Uterine Neoplasms 1 Urologic Neoplasms 1 Ureteral Neoplasms 1 Thyroid cancer, follicular 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Recurrence 1 Radiation Injuries 1 Prostate Adenocarcinoma 1 Platelet Glycoprotein IV Deficiency 1 Parotid Neoplasms 1

Interventions

Cyclophosphamide 153 Dexamethasone 140 Rituximab 84 fludarabine 79 Lenalidomide 72 Cytarabine 70 fludarabine phosphate 63 Bortezomib 63 Gemcitabine 62 venetoclax 54 Etoposide 53 pomalidomide 51 pembrolizumab 51 Paclitaxel 48 Cisplatin 48 Carboplatin 48 Peripheral Blood Stem Cell Transplantation 47 Filgrastim 40 Radiotherapy 39 Busulfan 37 Calcium Dobesilate 36 Methotrexate 34 Melphalan 34 Bevacizumab 33 carfilzomib 32 Cyclosporine 32 Azacitidine 32 Mycophenolic Acid 30 Vincristine 29 Nivolumab 29

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03230201 2017-08-08

UTUC

Peking University First Hospital

Phase NA Unknown

Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡